Protara Therapeutics Stock Options
| TARA Stock | USD 4.31 0.29 7.21% |
Protara Therapeutics' latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 1.68 with a put-to-call open interest ratio of 0.26 over 16 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on May 16th 2025.
Open Interest Against May 16th 2025 Option Contracts
2025-05-16
The chart above shows Protara Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Protara Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Protara Therapeutics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Protara Therapeutics
Analyzing Protara Therapeutics' in-the-money options over time can help investors to take a profitable long position in Protara Therapeutics regardless of its overall volatility. This is especially true when Protara Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Protara Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Protara Therapeutics' stock while costing only a fraction of its price.
Protara Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Protara Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Protara stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Protara Therapeutics' stock price goes up or down, the stock options follow.
At present, Protara Therapeutics' Common Stock Total Equity is projected to decrease significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 21.6 M, whereas Total Stockholder Equity is forecasted to decline to about 94.5 M. Protara Therapeutics In The Money Call Balance
When Protara Therapeutics' strike price is surpassing the current stock price, the option contract against Protara Therapeutics stock is said to be in the money. When it comes to buying Protara Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Protara Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Protara Current Options Market Mood
Protara Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Protara Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Protara Therapeutics' options investors are not very successful. Protara Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Protara contract
Base on the Rule 16, the options market is currently suggesting that Protara Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-05-16 option contract. With Protara Therapeutics trading at USD 4.31, that is roughly USD 0.004525. If you think that the market is fully incorporating Protara Therapeutics' daily price movement you should consider buying Protara Therapeutics options at the current volatility level of 1.68%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Protara |
Purchasing Protara Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Protara calls. Remember, the seller must deliver Protara Therapeutics stock to the call owner when a call is exercised.
Protara Therapeutics Option Chain
When Protara Therapeutics' strike price is surpassing the current stock price, the option contract against Protara Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Protara Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Protara. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Protara. It also shows strike prices and maturity days for a Protara Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TARA250516C00020000 | 10 | 20.0 | 0.0 - 0.15 | 0.22 | Out |
Call | TARA250516C00017500 | 20 | 17.5 | 0.0 - 0.25 | 0.08 | Out |
Call | TARA250516C00015000 | 218 | 15.0 | 0.0 - 0.35 | 0.1 | Out |
Call | TARA250516C00012500 | 34 | 12.5 | 0.0 - 0.25 | 0.18 | Out |
Call | TARA250516C00010000 | 375 | 10.0 | 0.0 - 0.6 | 0.1 | Out |
Call | TARA250516C00007500 | 305 | 7.5 | 0.1 - 0.5 | 0.22 | Out |
Call | TARA250516C00005000 | 986 | 5.0 | 0.35 - 0.9 | 0.81 | Out |
Call | TARA250516C00002500 | 22 | 2.5 | 1.75 - 2.25 | 2.4 | In |
Put | TARA250516P00020000 | 0 | 20.0 | 15.4 - 15.9 | 15.4 | In |
Put | TARA250516P00017500 | 0 | 17.5 | 12.9 - 13.5 | 12.9 | In |
Put | TARA250516P00015000 | 0 | 15.0 | 10.4 - 11.0 | 10.4 | In |
Put | TARA250516P00012500 | 0 | 12.5 | 8.0 - 8.5 | 8.0 | In |
Put | TARA250516P00010000 | 0 | 10.0 | 5.5 - 6.1 | 5.5 | In |
Put | TARA250516P00007500 | 6 | 7.5 | 3.2 - 3.8 | 3.01 | In |
Put | TARA250516P00005000 | 481 | 5.0 | 1.15 - 2.0 | 1.45 | In |
Put | TARA250516P00002500 | 33 | 2.5 | 0.0 - 0.3 | 0.25 | Out |
Protara Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Protara Total Stockholder Equity
Total Stockholder Equity |
|
Protara Therapeutics Corporate Management
| MBA MPH | VP CoFounder | Profile | |
| Jesse Shefferman | Principal CoFounder | Profile | |
| Jathin MD | Executive Officer | Profile | |
| Justine OMalley | Senior Affairs | Profile | |
| Kristine Rosse | VP Officer | Profile | |
| Patrick MBA | Chief Officer | Profile | |
| Mary JD | General Secretary | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Protara Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Protara Stock refer to our How to Trade Protara Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protara Therapeutics. If investors know Protara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protara Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Protara Therapeutics is measured differently than its book value, which is the value of Protara that is recorded on the company's balance sheet. Investors also form their own opinion of Protara Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protara Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protara Therapeutics' market value can be influenced by many factors that don't directly affect Protara Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protara Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.